GLP-1 receptor agonists are a pharmacologic treatment of type 2 diabetes with potential cardiorenal benefits.

Worse clinical outcomes are seen during the pandemic for non-Hispanic Black youth with T2D.

A1c goals are not a one-size-fits-all; here are some factors you might want to think about to help patients meet their target A1c goals. 

By Sheri Colberg, PhD
In the recent past, we discussed how to know if joint problems (e.g., overuse injuries) are due to being active, aging, or diabetes, but let's focus on aging by itself this time around. Of course, we'd all love to slow down normal aging or even reverse some aspects of it, but is that even possible?

Stroke has been linked to diabetes, but can analysis of fasting glucose provide greater insight into who is most at risk?

DPP-4i may lower the amyloid burden in Alzheimer’s patients and improve cognitive impairment. 

Are there predictors of glycemic worsening among patients recently diagnosed with type 2 diabetes?  

Weight loss surgery may change the way the brain responds to food cues. 

A loss of as little as 2-3% of a patient’s total body weight can help them achieve better blood glucose levels.

A recent study looked at how different diets can affect blood glucose levels in patients with type 1 diabetes.